The development of catalysts has long depended on trial-and-error methods, which are time-consuming and often yield ...

As the population continues to rise in Edmonton, BILD Edmonton Metro’s latest report makes the case for expanding outward by ...

Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association’s 85th Scientific Sessions with Simultaneous Publication in Diabetes Care ...

CATALYST was the largest and most rigorous trial ever conducted to assess the prevalence of hypercortisolism (Cushing’s syndrome) in patients with difficult-to-control type 2 diabetes.

Catalyst Clinical Research today proudly announces it has won the Excellence in Clinical Trial Management category in the Fierce CRO Awards by Fierce Biotech.

Treatment with mifepristone led to improved glycemic control and weight loss in patients with poorly controlled T2D and hypercortisolism, according to new data from the CATALYST trial.

The CATALYST trial is the first prospective, multicenter, double-blind, randomized, placebo-controlled study to demonstrate that mifepristone, a cortisol receptor blocker, improves glycemic ...

Tron: Catalyst is the latest title by Bithell Games, the studio created by Mike Bithell of Thomas was Alone fame. While the developer had previously entered the world of Disney’s Tron with a text ...

CATALYST was the largest and most rigorous trial ever conducted to assess the prevalence of hypercortisolism (Cushing’s syndrome) in patients with difficult-to-control type 2 diabetes.

WILMINGTON, N.C., June 18, 2025 /PRNewswire/ -- Catalyst Clinical Research today proudly announces it has won the Excellence in Clinical Trial Management category in the Fierce CRO Awards by ...